Menu
Currency
GWAS Study

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.

Walsh KM, Codd V, Smirnov IV et al.

24908248 PubMed ID
GWAS Study Type
9380 Participants
86 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WK
Walsh KM
CV
Codd V
SI
Smirnov IV
RT
Rice T
DP
Decker PA
HH
Hansen HM
KT
Kollmeyer T
KM
Kosel ML
MA
Molinaro AM
ML
McCoy LS
BP
Bracci PM
CB
Cabriga BS
PM
Pekmezci M
ZS
Zheng S
WJ
Wiemels JL
PA
Pico AR
TT
Tihan T
BM
Berger MS
CS
Chang SM
PM
Prados MD
LD
Lachance DH
OB
O'Neill BP
SH
Sicotte H
EJ
Eckel-Passow JE
VD
van der Harst P
WJ
Wiencke JK
SN
Samani NJ
JR
Jenkins RB
WM
Wrensch MR
Chapter II

Abstract

Summary of the research findings

Glioma, the most common central nervous system cancer in adults, has poor prognosis. Here we identify a new SNP associated with glioma risk, rs1920116 (near TERC), that reached genome-wide significance (Pcombined = 8.3 × 10(-9)) in a meta-analysis of genome-wide association studies (GWAS) of high-grade glioma and replication data (1,644 cases and 7,736 controls). This region has previously been associated with mean leukocyte telomere length (LTL). We therefore examined the relationship between LTL and both this new risk locus and other previously established risk loci for glioma using data from a recent GWAS of LTL (n = 37,684 individuals). Alleles associated with glioma risk near TERC and TERT were strongly associated with longer LTL (P = 5.5 × 10(-20) and 4.4 × 10(-19), respectively). In contrast, risk-associated alleles near RTEL1 were inconsistently associated with LTL, suggesting the presence of distinct causal alleles. No other risk loci for glioma were associated with LTL. The identification of risk alleles for glioma near TERC and TERT that also associate with telomere length implicates telomerase in gliomagenesis.

1,013 European ancestry cases, 6,595 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

9380
Total Participants
GWAS
Study Type
Yes
Replicated
631 European ancestry cases, 1,141 European ancestry controls
Replication Participants
European
Ancestry
U.S., Canada
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.